BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 33468080)

  • 1. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
    Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in
    Langouët M; Jolicoeur C; Javed A; Mattar P; Gearhart MD; Daiger SP; Bertelsen M; Tranebjærg L; Rendtorff ND; Grønskov K; Jespersgaard C; Chen R; Sun Z; Li H; Alirezaie N; Majewski J; Bardwell VJ; Sui R; Koenekoop RK; Cayouette M
    Sci Adv; 2022 Sep; 8(36):eabh2868. PubMed ID: 36070393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.
    Sun R; Wang J; Young KH
    Crit Rev Oncog; 2017; 22(5-6):527-557. PubMed ID: 29604930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes.
    Oon ML; Lim JQ; Lee B; Leong SM; Soon GS; Wong ZW; Lim EH; Li Z; Yeoh AEJ; Chen S; Ban KHK; Chung TH; Tan SY; Chuang SS; Kato S; Nakamura S; Takahashi E; Ho YH; Khoury JD; Au-Yeung RKH; Cheng CL; Lim ST; Chng WJ; Tripodo C; Rotzschke O; Ong CK; Ng SB
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and molecular genetic alterations in monomorphic-epitheliotropic intestinal T-cell lymphoma of the small intestine.
    Zhou B; Guo M; Li X; Duan T; Peng L; Hao H
    Eur J Med Res; 2024 Mar; 29(1):191. PubMed ID: 38520011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations of thymic epithelial tumors with myasthenia gravis.
    Pardini E; Cucchiara F; Palumbo S; Tarrini G; Di Vita A; Coppedè F; Nicolì V; Guida M; Maestri M; Ricciardi R; Aprile V; Ambrogi MC; Barachini S; Lucchi M; Petrini I
    Front Oncol; 2023; 13():1224491. PubMed ID: 37671056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.
    Major A; Porcu P; Haverkos BM
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer.
    Rack S; Feeney L; Hapuarachi B; Adderley H; Woodhouse L; Betts G; Burghel GJ; Harrington KJ; Metcalf R
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.
    Kim H; Ko YH
    Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.
    Roy A; Kumar V; Zorman B; Fang E; Haines KM; Doddapaneni H; Hampton OA; White S; Bavle AA; Patel NR; Eldin KW; John Hicks M; Rakheja D; Leavey PJ; Skapek SX; Amatruda JF; Nuchtern JG; Chintagumpala MM; Wheeler DA; Plon SE; Sumazin P; Parsons DW
    Nat Commun; 2015 Nov; 6():8891. PubMed ID: 26573325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
    Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
    Genes Chromosomes Cancer; 2016 May; 55(5):460-71. PubMed ID: 26773734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCOR gene alterations in hematologic diseases.
    Sportoletti P; Sorcini D; Falini B
    Blood; 2021 Dec; 138(24):2455-2468. PubMed ID: 33945606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear Cell Sarcoma of the Kidney.
    Aw SJ; Chang KTE
    Arch Pathol Lab Med; 2019 Aug; 143(8):1022-1026. PubMed ID: 30628851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
    Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
    BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.